These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 26899267)
1. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review. Vriend J; Reiter RJ Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
4. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron. Park SS; Bae I; Lee YJ J Cell Biochem; 2008 Apr; 103(6):1989-98. PubMed ID: 17973296 [TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. Cho SY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Chen CY; Lee EO; Kim SH J Pineal Res; 2011 Aug; 51(1):87-93. PubMed ID: 21392092 [TBL] [Abstract][Full Text] [Related]
6. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein. Yu F; White SB; Zhao Q; Lee FS Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837 [TBL] [Abstract][Full Text] [Related]
7. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
8. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. Jones MK; Szabó IL; Kawanaka H; Husain SS; Tarnawski AS FASEB J; 2002 Feb; 16(2):264-6. PubMed ID: 11772947 [TBL] [Abstract][Full Text] [Related]
9. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765 [TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795 [TBL] [Abstract][Full Text] [Related]
11. Activation of hypoxia-induced transcription in normoxia. Hägg M; Wennström S Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343 [TBL] [Abstract][Full Text] [Related]
12. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Maynard MA; Ohh M Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728 [TBL] [Abstract][Full Text] [Related]
13. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases. Paltoglou S; Roberts BJ Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177 [TBL] [Abstract][Full Text] [Related]
14. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells. Kwon SJ; Song JJ; Lee YJ Clin Cancer Res; 2005 Nov; 11(21):7607-13. PubMed ID: 16278378 [TBL] [Abstract][Full Text] [Related]
15. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity. Lewis MD; Roberts BJ Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Tanimoto K; Makino Y; Pereira T; Poellinger L EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113 [TBL] [Abstract][Full Text] [Related]
17. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
18. Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein. Frost J; Rocha S; Ciulli A J Biol Chem; 2021 Aug; 297(2):100910. PubMed ID: 34174286 [TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells. Sasabe E; Yang Z; Ohno S; Yamamoto T Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165 [TBL] [Abstract][Full Text] [Related]
20. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Mahon PC; Hirota K; Semenza GL Genes Dev; 2001 Oct; 15(20):2675-86. PubMed ID: 11641274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]